These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Hormone receptors and target cell responsiveness. Jänne OA; Kontula KK Ann Clin Res; 1980 Oct; 12(5):174-91. PubMed ID: 6263168 [TBL] [Abstract][Full Text] [Related]
27. Soluble complexes between steroid hormones and target-tissue receptors bind specifically to target-tissue chromatin. Steggles AW; Spelsberg TC; Glasser SR; O'Malley BW Proc Natl Acad Sci U S A; 1971 Jul; 68(7):1479-82. PubMed ID: 5283938 [TBL] [Abstract][Full Text] [Related]
28. Cytoplasmic and nuclear binding components for 1alpha25-dihydroxyvitamin D3 in chick parathyroid glands. Brumbaugh PF; Hughes MR; Haussler MR Proc Natl Acad Sci U S A; 1975 Dec; 72(12):4871-5. PubMed ID: 1061076 [TBL] [Abstract][Full Text] [Related]
29. The properties of a nuclear acidic protein fraction that binds [6,7-3H]oestradiol-17beta. King RJ; Gordon J; Steggles AW Biochem J; 1969 Sep; 114(3):649-57. PubMed ID: 4897941 [TBL] [Abstract][Full Text] [Related]
30. 5alpha-Dihydrotestosterone (DHT) receptors in rat brain and pituitary cell nuclei. Lieberburg I; Maclusky NJ; McEwen BS Endocrinology; 1977 Feb; 100(2):598-607. PubMed ID: 832639 [TBL] [Abstract][Full Text] [Related]
31. Steroid receptor forms and their interaction with cytoplasmic modulators. Sato B; Nishizawa Y; Maeda Y; Noma K; Honma T; Matsumoto K J Steroid Biochem; 1983 Jul; 19(1A):315-21. PubMed ID: 6887866 [TBL] [Abstract][Full Text] [Related]
32. Inability of cytoplasmic or nuclear androgen receptor content or distribution to distinguish benign from carcinomatous human prostate. Shain SA; Gorelic LS; Klipper RW; Ramzy I; Novicki DE; Radwin HM; Lamm DL Cancer Res; 1983 Aug; 43(8):3691-5. PubMed ID: 6861139 [TBL] [Abstract][Full Text] [Related]
33. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Pratt WB; Toft DO Endocr Rev; 1997 Jun; 18(3):306-60. PubMed ID: 9183567 [TBL] [Abstract][Full Text] [Related]
34. Androgen-binding proteins in human benign prostatic hypertrophy. Rosen V; Jung I; Baulieu EE; Robel P J Clin Endocrinol Metab; 1975 Oct; 41(4):761-70. PubMed ID: 51854 [TBL] [Abstract][Full Text] [Related]
35. Characterization of two nuclear androgen receptors in Atlantic croaker: comparison of their biochemical properties and binding specificities. Sperry TS; Thomas P Endocrinology; 1999 Apr; 140(4):1602-11. PubMed ID: 10098494 [TBL] [Abstract][Full Text] [Related]
36. Methods for ligand-receptor assays in clinical chemistry. Smith RG; Sestili MA Clin Chem; 1980 Apr; 26(5):543-50. PubMed ID: 6266695 [TBL] [Abstract][Full Text] [Related]
37. Identification of a high affinity nuclear acceptor site for estrogen receptor of calf uterus. Puca GA; Sica V; Nola E Proc Natl Acad Sci U S A; 1974 Mar; 71(3):979-83. PubMed ID: 4362642 [TBL] [Abstract][Full Text] [Related]
38. An approach to the anabolic action of androgens by an experimental system. Michel G; Baulieu EE Environ Qual Saf Suppl; 1976; (5):54-9. PubMed ID: 182485 [TBL] [Abstract][Full Text] [Related]
39. A reconstituted cell-free system for the specific transfer of steroid--receptor complexes into nuclear chromatin isolated from the rat ventral prostate gland. Mainwaring WI; Peterken BM Biochem J; 1971 Nov; 125(1):285-95. PubMed ID: 5158914 [TBL] [Abstract][Full Text] [Related]
40. Prealbumin and the thyroid hormone nuclear receptor. Blake CC Proc R Soc Lond B Biol Sci; 1981 Mar; 211(1185):413-31. PubMed ID: 6112755 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]